September 21, 2021 – Today Divergence Neuro Technologies Inc. (Divergence) and the Centre for Neurology Studies (CNS) are announcing that they have entered into a joint collaboration to provide a one-stop-shop for researchers who need stronger project support and better data analytics and tools.

With the CNS’ expertise in clinical trial design, study execution and professional consulting combined with Divergence’s expertise in data analytics, machine learning and artificial intelligence, the two companies are able to provide a comprehensive set of services to any researchers looking to advance their neuroscience project objectives.

“We are very excited to be able to offer our research customers a more robust set of services through this collaboration with CNS,” said Alex Ni, CEO of Divergence. “Researchers can now get everything they need to ideate, design, execute, analyze and complete their projects from this joint collaboration.”

“We look forward to working with the like-minded team at Divergence, as we share the same goal of positively impacting brain health,” said Sonia Brodie, VP Services at the CNS. “Joining forces with such complementary skill sets will allow us to tackle some very cool projects together!”

About the Centre for Neurology Studies (CNS)

The CNS is a Clinical Research Site providing professional consulting and study execution services to get important breakthroughs in healthcare one step closer to market. As a wholly owned subsidiary of HealthTech Connex Inc., the CNS is integrated within the Surrey Neuroplasticity Clinic, a boutique neurorehabilitation clinic specializing in physical, cognitive, and mental health interventions. The CNS is also affiliated with the NeuroCatch™ Platform – an easy-to-use, objective, rapid neuro-physiological brain function assessment system that is currently licensed by Health Canada as a Class II medical device.

About Divergence Neuro Technologies Inc.

Divergence is a technology company focused on providing a platform for Mental Healthcare Providers that allows for a stronger connection to their patients during remote and between sessions. The platform allows for the collection of EEG and other biometric and subjective assessment data from research studies that can be used in a variety of ways including novel treatment prediction models, proving treatment efficacy, and more.